Creative Biolabs has developed a multi-layered model system and offers the global community preclinical research tools that better mimic human physiological characteristics.In vivo disease models bridge the gap between the fundamental science and the drug candidate validation. The rodent models have long been used to understand the cancer mechanisms, immune system responses, and drug action pathways, and model relevance is being enhanced by genetic engineering and humanization technologies."Successful drug discovery increasingly depends on the biological relevance of the models," said the…
Combines single-organ, multi-organ, and higher-throughput configurations within one scalable platform
Fully compatible with existing PhysioMimix accessories, validated protocols, consumables, and organ model kits for seamless workflow integration
Cambridge, UK, 14 October 2025: CN Bio, a leading provider of benchtop Organ-on-a-chip (OOC) solutions that accelerate drug discovery and development, today announced the launch of PhysioMimix® Core. Combining the capabilities of CN Bio’s existing suite of instruments, PhysioMimix Core is the first OOC solution to deliver validated performance…
Amsbio has launched over a range of over 30 independently developed and manufactured organoid culture-related cytokines for researchers working with stem cells and induced pluripotent stem cells (iPSCs). This new range of cytokines is tailored for and validated in organoid culture, ensuring high compatibility and making your research more controlled and reproducible.
In a growing number of research areas, organoids have become a key cell culture tool, widely applied in development and disease modelling, precision medicine, toxicology studies, and regenerative medicine.…
LONDON, October 14, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Proveca Ltd (“Proveca”) and is pleased to announce the placement of Gregory Reinaud as Chief Operating Officer (COO).Proveca is a specialist pharmaceutical company dedicated to providing licensed medicines for children. The Company develops and licenses medicines for children with long-term, chronic conditions, addressing the significant issue of children being prescribed adult…
On Wednesday, 15 October, One Nucleus is partnering with Longfellow to host the very first Elevate event at the newly completed Cam3 building on the CamLIFE campus in Cambridge.
Titled Breakfast and Brilliance, the morning will offer just that: a delicious breakfast, opportunities to connect with fellow life science professionals, and an inspiring keynote from Brendan Hall.
Brendan skippered a racing yacht in the legendary Clipper Round the World Yacht Race—a 35,000-mile circumnavigation with amateur crews competing in identical boats. Though he was the youngest and least experienced skipper…
Sandwich, UK - 11 October 2025: A new science specialist sixth form is set to open next year, based at Sandwich science and innovation campus, Discovery Park.
The new sixth form is named Carbon 6 Academy of Science, ideal for ambitious students aged 16-18 with a passion for science and maths. The academy is designed for those looking to pursue a STEM career, setting students up for success with routes into further education including degree apprenticeships and university study.
The unique location within a world-class science park gives students access to state-of-the-art professional…
After 23 years in business, Spinning Clock Limited is turning the page with a bold new brand identity and new headquarters. Now known simply as CLOK, the company has rebranded to reflect their values of precision, clarity and creativity – and has relocated from Nottingham to a newly converted commercial barn nestled between Center Parcs and Sherwood Pines.
Founded in 2002, the company has grown from its roots as a creative agency into a trusted partner for its client's seeking clarity, precision, and results. CLOK is proudly the same limited company that was formed 23 years ago in 2002 and…
Health Innovation West Midlands (HIWM), which accelerates the adoption and spread of transformative health innovations, is now based at PHTA Ltd – supporting innovators and local entrepreneurs to speed up development and clinical rollout. As part of the national Health Innovation Network, funded by NHS England, HIWM catalyses collaboration between academia, industry, health and care providers, commissioners and citizens, supporting the development of healthcare innovations and giving patients access to the most effective medical discoveries, sooner. Since it was established in 2013…
Edinburgh and Cambridge, UK, 8 October 2025 - Macomics Ltd, a leader in macrophage drug discovery, announces that it has validated its ENIGMAC™ platform in neurodegeneration and neuroinflammation applications.
Macomics’ ENIGMAC drug discovery platform is designed to discover therapeutic targets and unlock disease specific target biology. The platform enables identification and validation of novel targets and provides a translationally relevant path to the clinic through the development of more physiologically relevant human models combined with proprietary gene editing technology.
There is…
Medicines Discovery Catapult (MDC) has been announced as the newest Innovate UK Knowledge Transfer Partnership (KTP) Knowledge Base, helping UK life science businesses innovate and grow through strategic partnership.
MDC is uniquely placed as a Knowledge Base to provide collaborative partnerships in translational drug discovery and commercialisation. Through the programme, MDC will help life sciences businesses turn their ideas into impact, equipping them with the knowledge and capabilities needed to validate their innovations and bring game-changing solutions to patients faster.
Now in…